Nathan Kraynack is a Respiratory physician. OpenAlex indexes 7 publications with 309 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Perkins Sq
Akron, OH 443081063
Telephone
330-543-8009Registry record last updated 8 Jul 2007.
Clinical trials
- Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis
Sponsor: Akron Children's Hospital
- Effect of Simvastatin on CF Airway Inflammation
Sponsor: Akron Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mylan Specialty L.P.Program year20241 payment
- Mylan Specialty L.P.Program year20231 payment
- Mylan Specialty L.P.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Polymyxin-class Antibacterial100%Colistimethate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of Enrollment in an Aerodigestive Clinic With Reduced Hospital Stay for Children With Special Health Care Needs
JAMA Otolaryngology–Head & Neck Surgery
2017 - Approach to treating cystic fibrosis pulmonary exacerbations varies widely across us CF care centers
Pediatric Pulmonology
2011 - Improving Care at Cystic Fibrosis Centers through Quality Improvement
Seminars in Respiratory and Critical Care Medicine
2009 - Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells
American Journal of Physiology-Lung Cellular and Molecular Physiology
2003 - Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells
American Journal of Physiology-Lung Cellular and Molecular Physiology
2002
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”